Clinical Trial Update: Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating decitabine in combination with tretinoin in patients with myelodysplastic syndromes has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)
• TRETINOIN (TRETINOIN)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-20